T2-STIR CMR imaging can be used to assess myocardium at risk with gadolinium present in an experimental setting
Main Authors: | Nordlund, David, Kanski, Mikael, Jablonowski, Robert, Ubachs, Joey F, Koul, Sasha, van der Pals, Jesper, Carlsson, Marcus, Erlinge, David, Arheden, Hakan, Engblom, Henrik |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559769/ |
Similar Items
-
Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo
by: Jablonowski, Robert, et al.
Published: (2013) -
Infarct size is overestimated by contrast-enhanced CMR in the acute phase but not at 7 days when compared with histopathology
by: Jablonowski, Robert, et al.
Published: (2014) -
Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery, validation in patients and ex vivo
by: Jablonowski, Robert, et al.
Published: (2012) -
Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
by: Nordlund, David, et al.
Published: (2016) -
The evolution of myocardium at risk by T2-STIR MR imaging the first week after acute myocardial ischemia
by: Nordlund, David, et al.
Published: (2016)